CD-ROM

Nucleic acid based HIV and SIV therapies

Presentation type		Track	Abstract category	Text
All Oral abstracts Poster Discussions Poster Exhibition CD-ROM		All A B C D	All Acute and early infection Acute and early infection and management of patients with acquired viral resistance Adherence in adults Adherence in children and adolescents Ageing AIDS related malignancies (KS, lymphoma, cervical and anal carcinoma) including HHV8 infection Animal Models Animal models of transmission, disease resistance and progression Antibody based vaccines Antiretroviral Therapies (strategic categories apply to resource rich and constrained settings) in Children and Adolescents Antiretroviral therapy,clinical trials and cohorts Antiretroviral treatment of people living with HIV for prevention Approaches to counselling and testing in children and caregivers Behavioural surveillance Bioinformatic analysis in drug resistance Bioinformatics analysis of viral diversity in natural history Blood, organ and tissue safety and nosocomial transmission Cellular immunity based vaccines Clinical trials Cohort studies Complementary and traditional medicines and the role of traditional healers in therapy Complications of Anti-Retroviral Therapy and Adherence in Adults and Children Correlates of immune protection Diagnosis of HIV disease Diagnostic Tools for the Immunological and Virological Monitoring of HIV Infection Disease burden – morbidity/mortality Epidemiology of HIV in people who use drugs Epidemiology of sexually transmitted infections (STI) and HIV Estimating the need for HIV treatment Estimating the size of HIV-infected and most at risk population Ethical issues in epidemiological research First line therapy Harm reduction, including reduction of unsafe injecting and other approaches Hepatitis co-infections: (including HBV, HCV) HIV counselling, testing and diagnostic strategies HIV diversity and epidemiology HIV Pathogenesis/Immune Function and Dysfunction HIV Pathogenesis/Latency and Viral Reservoirs HIV superinfections HIV Surveillance, Monitoring and Evaluation HIV tropism, dynamics and fitness HIV-1 and HIV-2 co-infections HIV-2 Host genetics of resistance and susceptibility Immune reconstitution disorders / IRIS Impact of nutrition Innate immunity responses and function in natural history of HIV infection Malaria Male and female condoms and other physical barriers Male circumcision Management of late presenters Measuring and modelling the effect and impact of other HIV prevention interventions Measuring and modelling the effect and impact of PMTCT Measuring and modelling the impact of the HIV epidemic Mechanisms of T cell depletion and dysfunction Methodological Issues and Capacity-Building in Epidemiology and Prevention Research Microbicides Monitoring and evaluation (other) Monitoring and evaluation of HIV prevention, care and treatment Mother to child transmission Mucosal immunity/defenses: responses and dysfunction Mucosal transmission Mycobacteria and TB Natural history, progression and survival Neurologic and psychiatric manifestations, including neurocognitive disorders New HIV testing and diagnostic strategies New monitoring strategies including rapid tests Non pathogenic models of SIV Non-AIDS related co-morbidities (e.g. diabetes, hypertension etc) Non-AIDS related malignancies Novel animal models for vaccine and inhibitor development Novel assays of immune responses Novel Treatment and Prevention Strategies Novel vectors and strategies Nucleic acid based HIV and SIV therapies Opportunistic infections (excluding mycobacterial) Other adverse reactions and complications of ARV therapy Other bacterial infections and malaria and parasitic infections Other complications Other Therapies Paediatric surveillance of HIV Pharmacogenomics Pharmacology, pharmacokinetics, drug formulations Population-based surveys with HIV testing Preclinical development of microbicides Pre-exposure and post-exposure prophylaxis Prevention addressing gender inequalities Prevention for men who have sex with men (MSM) Prevention for people living with HIV Prevention for people who use drugs Prevention for the general population Prevention in institutional settings e.g. workplace, school, prison, military Prevention of mother-to-child transmission Prophylaxis of HIV associated infections; vaccines e.g. pneumococcal, hepatitis and HPV, co-trimoxazole prophylaxis and IPT Research designs in epidemiology Sexually transmitted infections (STI) Simplification strategies (induction/maintenance and use of bPI monotherapy) STI prevention and control Surveillance of HIV (Youth and Adults) Surveillance systems and methods Switch studies Therapy for the heavily pre-treated patient Track B - Clinical Sciences Track C: Epidemiology and Prevention Sciences Transmission and Early Infection Tuberculosis Viral determinants of SIV pathogenesis Viral fitness and tropism assays, utility and application in clinical practice Viral resistance testing in clinical trials and practice Virus-specific cellular immunity When to start therapy
Late breakers only

Posters with this symbol have been selected by the Scientific Programme Committee for distinction based on merit.

Posters with this symbol have an e-Poster available.

CDA049 Abstract Spreading epidemic of protease codon 35 inserted strains from HIV-1 subtype C in Portugal V. Duque1, J. Pereira-Vaz1, C. Valente2, C. Morais1, V. Mota1, J.G. Saraiva-da-Cunha3, A. Meliço-Silvestre3 1Hospitais da Universidade de Coimbra, Laboratório de Virologia do Departamento de Doenças Infecciosas, Coimbra, Portugal, 2Centro Hospitalar de Coimbra, Serviço de Doenças Infecciosas, Coimbra, Portugal, 3Hospitais da Universidade de Coimbra, Departamento de Doenças Infecciosas, Coimbra, Portugal CDA050 Abstract Near full-length genome characterization of HIV-1 intrasubtype B clusters and recombinants in Panama S.M. Ahumada-Ruiz1,2, D. Flores-Figueroa3, I. Toala-González3, M.M. Thomson1 1Instituto de Salud Carlos III, Madrid, Spain, Departamento de Patogenia Viral, Centro Nacional de Microbiología, Madrid, Spain, 2Universidad de Panamá, Laboratorio de Microbiología Experimental y Aplicada, Panamá, Panama, 3Caja del Seguro Social de Panamá, Departamento de Enfermedades Infecciosas, Panamá, Panama CDA051 Abstract Prevalence and resistance mutations of non-B HIV subtypes among immigrants in Southern Spain B. de Felipe1, P. Viciana1, L.F. Lopez-Cortes1, F. Fernandez-Cuerda2, M. Trastoy1, R. Mata1, M. Leal1, A. Vallejo1 1Hospital Virgen del Rocio, Infectious Diseases Service, Seville, Spain, 2Hospital Virgen Macarena, Microbiology Service, Seville, Spain CDA052 Abstract Characterization of HIV-1 CRF01_AE integrase gene in a cohort of Vietnamese drug users R. Barbara1, C. Wanke2, H. Nguyen3, L. Trinh3, D. Dang3, M. Jordan4 1Tufts University, Geographic Medicine and Infectious Disease, Boston, United States, 2Tufts University, Boston, United States, 3National Institute of Infectious and Tropical Diseases, Hanoi, Viet Nam, 4Tufts University School of Medicine, Infectious Disease and Geographic Medicine, Boston, United States CDA053 Abstract High HIV-1 genetic complexity in men who have sex with men (MSM) in Bangkok, Thailand W. Leelawiwat1, M. Arroyo2, F. Mueanpai1, O. Kongpechsatit1, C. Kittinunvorakoon1, V. Assawadarachai2, M. de Souza2, S. Chaikummao1, W. Chonwattana1, J. Tongtoyai1, A. Sangiamkittikul1, F. van Griensven1,3, J. Mcnicholl1,4 1Thailand MOPH - U.S. CDC Collaboration, Nonthaburi, Thailand, 2The Armed Forces Research Institute of Medical Sciences, Department of Retrovirology, Bangkok, Thailand, 3Centers for Disease Control and Prevention, Atlanta, GA, United States, 4Centers for Disease Control and Prevention, Atlanta, United States CDA054 Abstract Impact of treatment with reverse transcriptase inhibitors on the variation of protease region among HIV-1 infected individuals S. Uma1, S. Suniti1, K.G. Murugavel1, N. Kumarasamy1, S.S. Sunil1, H.M. Kenneth2, P. Balakrishnan1 1Y.R.Gaitonde Centre for AIDS Research and Education, Chennai, India, 2Brown University/Miriam Hospital, Providence, United States CDA055 Abstract Analysis of the mean increase in CD4 cell counts and viral load decrease between different subtypes C, CRF31_BC, B and F after initial antiretroviral therapy in a Porto Alegre HIV clinic, southern of Brazil C. Nunes1, C. Dias1, I. Lamego1, L. Brigido2 1Porto Alegre City Bureau of Healthy, HIV Clinic, Porto Alegre, Brazil, 2Adolfo Lutz, Virology Laboratory, Sao Paulo, Brazil CDA056 Abstract High frequency of SI/X4 phenotype and ex vivo replicative capacity in CRF14_BG primary isolates compared with their parental subtypes B and G M. Muñoz-Nieto1, M.T. Cuevas2, A. Fernández-Garcia2, M. Pinilla2, A. Ocampo3, V. García2, E. Delgado2, A.M. Sánchez2, M. Thomson2, L. Pérez-Álvarez2 1Centro Nacional de Microbiología. Instituto de Salud Carlos III, Madrid, Spain, 2Patogenia viral. Centro Nacional de Microbiología. Instituto de Salud Carlos III, Madrid, Spain, 3Complejo Hospitalario Xeral-Cíes., Vigo, Pontevedra, Spain CDA057 Abstract Quantification of plasma HIV-RNA levels in non-B subtypes and URFs with three commercial assays B. Bruzzone1, P. Caligiuri2, F. Bisio3, N. Nigro1, A. Ventura2, F. Mayinda Mboungou4, L. Miguel4, A. Nzagou4, E. Malfatti5, C. Viscoli3, G. Icardi2 1San Martino Hospital, Hygiene Unit, Genoa, Italy, 2University of Genoa, Health Sciences, Genoa, Italy, 3University and San Martino Hospital, Infectious Disease Unit, Genoa, Italy, 4Kento-Muana Laboratory, Pointe Noire, Congo, 5Eni Foundation, Rome, Italy CDA058 Abstract Development of real time PCR targeting protease to discriminate HIV-1 from subtypes B and F D. Teixeira, P. Munerato, S.C.V. Komninakis, E.E. Fusuma, M.C.A. Sucupira, R.S. Diaz Federal University of São Paulo, Medicine Department, São Paulo, Brazil CDA059 Abstract Genetic characterization of HIV-1 among antiretroviral-naïve persons in rural Western Kenya L. Nafisa1, S. Inzaule1, A. Kasembeli1, H. Musuluma1, B. Oyaro1, J. Okonji1, T. Thomas2, H. Vandenhoudt3, P. Amornkul4, K. Laserson2, C. Zeh2 1Kenya Medical Research Institute (KEMRI), HIV-Research, Kisumu, Kenya, 2US Centers for Disease Control and Prevention, Lab, Kisumu, Kenya, 3KEMRI/Institute of Tropical Medicine, Lab, Kisumu, Kenya, 4International AIDS Vaccine Initiative USA, Lab, California, United States CDA060 Abstract Genetic diversity and antiretroviral drug resistance mutations in HIV-1 infected patients from Cape Verde Islands V. Oliveira1, I. Bártolo2, E. Valadas3, J. Barreto4, E. Almeida4, F. Antunes3, N. Taveira5,6 1IPO, Lisboa, Portugal, 2Faculdade de Farmácia de Lisboa, URIA-CPM, Lisboa, Portugal, 3Clínica Universitária de Doenças Infecciosas/Serviço de Doenças Infecciosas, Faculdade de Medicina de Lisboa/Hospital de Santa Maria, Lisboa, Portugal, 4Hospital Dr. Agostinho Neto, Cidade da Praia, Cape Verde, 5Instituto Superior de Ciências da Saúde Egas Moniz, Almada, Portugal, 6Faculdade de Farmácia de Lisboa, URIA-CPM, Microbiologia, Lisboa, Portugal